comparemela.com

Latest Breaking News On - Redefining cardiometabolic - Page 1 : comparemela.com

SGLT2 Inhibitors Could Reduce Risk of Lupus Nephritis and Dialysis in Systemic Lupus Erythematosus

A propensity score matched analysis suggests use of SGLT2 inhibitors could reduce risk of negative outcomes in patients with systemic lupus erythematosus and type 2 diabetes.

SMART-C Meta-Analysis: SGLT2 Inhibitors Reduce Cardiovascular Events

Empagliflozin Misses Primary Endpoint in Post-MI Patient Population, EMPACT-MI Trial

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.